Baumann M A, Libnoch J A, Hansen R M, Heckman M G, Hanson G A
Q J Med. 1985 Jun;55(218):199-211.
The lymphoproliferative disorders and the myelodysplastic syndromes are thought to result from the clonal expansion of a single abnormal precursor cell. Seven patients who were found to have concurrent myelodysplasia and lymphoproliferation are described. In all cases myelodysplasia and lymphoproliferation were diagnosed simultaneously or myelodysplasia preceded overt lymphoproliferation by a brief interval. Thus, myelodysplasia in these patients was not related to treatment given for a lymphoproliferative disorder. Stem cell theory is reviewed with special reference to evidence for an adult human stem cell common to both haemopoietic and lymphoid cell lines (CFU-L-M). The presence of concurrent myelodysplasia and lymphoproliferation in these seven patients may be the result of the clonal expansion of an abnormal pluripotential stem cell. It may be possible in some cases to achieve remission of the lymphoproliferative disorder with return of normal haematopoiesis if residual normal stem cells are present and repopulate the marrow following cytotoxic therapy.
淋巴增生性疾病和骨髓增生异常综合征被认为是由单个异常前体细胞的克隆性扩增引起的。本文描述了7例同时患有骨髓增生异常和淋巴增生的患者。在所有病例中,骨髓增生异常和淋巴增生均同时被诊断出来,或者骨髓增生异常在明显的淋巴增生之前出现,间隔时间较短。因此,这些患者的骨髓增生异常与针对淋巴增生性疾病的治疗无关。对干细胞理论进行了综述,并特别提及了造血和淋巴细胞系共同的成人人类干细胞(CFU-L-M)的证据。这7例患者同时存在骨髓增生异常和淋巴增生,可能是异常多能干细胞克隆性扩增的结果。如果存在残留的正常干细胞,并且在细胞毒性治疗后重新填充骨髓,那么在某些情况下,有可能使淋巴增生性疾病缓解,并恢复正常造血。